Self-emulsifying drug delivery systems: An approach to enhance oral bioavailability

Drug Discovery Today

Volumn 15, Issue 21-22, 2010, Pages 958-965

  Kohli, Kanchan ^a   Chopra, Sunny ^a   Dhar, Deepika ^b   Arora, Saurabh ^a   Khar, Roop K ^a  

^a HAMDARD UNIVERSITY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; CARVEDILOL; CELECOXIB; CYCLOSPORIN; CYCLOSPORIN A; EMULSIFYING AGENT; IBUPROFEN; INDOMETACIN; ISOTRETINOIN; KETOPROFEN; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; ONTAZOLAST; PACLITAXEL; PANIMUM BIORAL; PNU 91325; RAMIPRIL; RETINOIC ACID; RITONAVIR; SANQUINAVIR; SAQUINAVIR; SIMVASTATIN; TIPRANAVIR; UBIDECARENONE; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; ELECTRON MICROSCOPY; HUMAN; IN VITRO STUDY; LIPOLYSIS; LIQUEFACTION; NONHUMAN; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; EXCIPIENTS; HUMANS; LIPIDS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 78349310868     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.08.007     Document Type: Review

References (61)

1. Tang J.L., et al. Self emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Curr. Drug Ther. 2007, 2:85-93.
2. Humberstone A.J., Charman W.N. Lipid based vehicles for oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 1997, 25:103-128.
3. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 2000, 11(Suppl. 2):S93-S98.
4. Venkatesh G., et al. In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev. Ind. Pharm. 2010, 36:735-745.
5. Gursoy R.N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 2004, 58:173-182.
6. Singh B., et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit. Rev. Ther. Drug Carrier Syst. 2009, 26:427-521.
7. O'Driscoll C.M., Griffin B.T. Biopharmaceutical challenges associated with drugs with low aqueous solubility - the potential impact of lipid-based formulations. Adv. Drug Deliv. Rev. 2008, 60:617-624.
8. Pouton C.W., Porter C.J. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 2008, 60:625-637.
9. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006, 29:278-287.
10. Chen M.L. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv. Drug Deliv. Rev. 2008, 60:768-777.
11. Swenson E.S., et al. Intestinal permeability enhancement: efficacy, acute local toxicity and reversibility. Pharm. Res. 1994, 11:1132-1142.
12. Patel D., Sawant K.K. Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr. Drug Deliv. 2009, 6:419-424.
13. Silva B.F., et al. Size, shape, and charge of salt-free catanionic microemulsion droplets: a small-angle neutron scattering and modeling study. J. Phys. Chem. B 2009, 113:10230-10239.
14. Gershanik T., Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophillic drugs. Eur. J. Pharm. Biopharm. 2000, 50:179-188.
15. Devani M., et al. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J. Pharm. Pharmacol. 2004, 56:307-316.
16. Odeberg J.M., et al. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur. J. Pharm. Sci. 2003, 20:375-382.
17. Constantinides P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 1995, 12:1561-1572.
18. Kimura M., et al. Relationship between the molecular structures and emulsification properties of edible oils. Biosci. Biotechnol. Biochem. 1994, 58:1258-1261.
19. Hauss D.J., et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 1998, 87:164-169.
20. Shah N.H., et al. Self emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 1994, 106:15-23.
21. Attwood D., Florence A.T. Surfactant Systems: Their Chemistry, Pharmacy and Biology 1983, Chapman and Hall.
22. Werkley M.G., et al. Self emulsification of vegetable oil-non-ionic surfactant mixtures. ACS Symp. Ser. 1986, 311:242-255.
23. Meinzer A., et al. Microemulsion: a suitable galenical approach for the absorption enhancement of low soluble compounds?. BT Gattefosse 1995, 88:21-26.
24. Vonderscher J., Meinzer A. Rationale for the development of Sandimmune Neoral. Transplantation Proceedings (Vol. 26) 1994, 2925-2927.
25. Reiss H. Entropy induced dispersion of bulk liquids. J. Colloid Interface Sci. 1975, 53:61-70.
26. Craig D.Q., et al. An investigation into the mechanism of self emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 1995, 114:103-110.
27. Porter C.J., Charman W.N. In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev. 2001, 50(Suppl. 1):S127-S147.
28. Dressman J.B., et al. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 1998, 15:11-22.
29. Horter D., Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 2001, 46:75-87.
30. Hernell O., et al. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption, 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 1990, 29:2041-2056.
31. Fausa O. Duodenal bile acids after a test meal. Scand. J. Gastroenterol. 1974, 9:567-570.
32. Galia E., et al. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 1998, 15:698-705.
33. Dressman J.B., Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 2000, 11(Suppl. 2):S73-S80.
34. Nicolaides E., et al. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res. 2001, 18:380-388.
35. Porter C.J., et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 2008, 60:673-691.
36. Fatouros D.G., et al. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm. Res. 2007, 24:1844-1853.
37. Fatouros D.G., et al. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur. J. Pharm. Sci. 2007, 31:85-94.
38. Sek L., et al. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone. J. Pharm. Pharmacol. 2010, 58:809-820.
39. Cui S.X., et al. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev. Ind. Pharm. 2009, 35:603-611.
40. Wei L., et al. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev. Ind. Pharm. 2005, 31:785-794.
41. Pouton C.W., et al. Self-emulsifying systems for oral delivery of drugs. International Symposium on Control Release Bioactive Materials 1987, 113-114.
42. Gursoy N., et al. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J. Pharm. Sci. 2003, 92:2411-2418.
43. Nazzal S., et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 2002, 235:247-265.
44. Palamakula A., Khan M.A. Evaluation of cytotoxicity of oils used in coenzyme Q10 self-emulsifying drug delivery systems (SEDDS). Int. J. Pharm. 2004, 273:63-73.
45. Subramanian N., et al. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull. 2004, 27:1993-1999.
46. Goddeeris C., et al. Light scattering measurements on microemulsions: estimation of droplet sizes. Int. J. Pharm. 2006, 312:187-195.
47. Yang S., et al. Enhanced oral absorption of paclitaxel in a novel self microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm. Res. 2004, 21:261-270.
48. Vyas S.P., Khar R.K. Submicron emulsion. Targeted and Controlled Drug Delivery Novel Carriers Systems 2002, CBS Publishers and Distributors, pp. 291-294.
49. Craig D.Q., et al. An investigation into the physicochemical properties of self emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int. J. Pharm. 1993, 96:147-155.
50. Gershanik T., Benita S. Positively charged self-emulsifying oil formulation for improving the oral bioavailability of progestrone. Pharm. Dev. Technol. 1996, 1:147-157.
51. Pouton C.W. Formulation of self emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 1997, 25:47-58.
52. Attama A.A., et al. The use of solid self-emulsifying systems in the delivery of diclofenac. Int. J. Pharm. 2003, 262:23-28.
53. Patel D., Sawant K.K. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev. Ind. Pharm. 2007, 33:1318-1326.
54. Porter C.J., et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 2007, 6:231-248.
55. Kim J.Y., Ku Y.S. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int. J. Pharm. 2000, 194:81-89.
56. Kommuru T.R., et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212:233-246.
57. Kang B.K., et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 2004, 274:65-73.
58. Gao P., et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci. 2003, 92:2386-2398.
59. Shafiq S., et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 2007, 66:227-243.
60. Araya H., et al. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion II: stable gastrointestinal absorption of a poorly water soluble new compound, ER-1258 in bile-fistula rats. Drug Metab. Pharmacokinet. 2005, 20:257-267.
61. Gao P., et al. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev. Ind. Pharm. 2004, 30:221-229.